Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 42 Records) |
Query Trace: Disease Progression and BRCA1[original query] |
---|
Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast Cancer. Cancer research 2018 Nov 78 (21): 6329-6338. Li Jingmei, Ugalde-Morales Emilio, Wen Wei Xiong, Decker Brennan, Eriksson Mikael, Torstensson Astrid, Christensen Helene Nordahl, Dunning Alison M, Allen Jamie, Luccarini Craig, Pooley Karen A, Simard Jacques, Dorling Leila, Easton Douglas F, Teo Soo Hwang, Hall Per, Czene Kami |
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. The New England journal of medicine 2018 10 379 (26): 2495-2505. Moore Kathleen, Colombo Nicoletta, Scambia Giovanni, Kim Byoung-Gie, Oaknin Ana, Friedlander Michael, Lisyanskaya Alla, Floquet Anne, Leary Alexandra, Sonke Gabe S, Gourley Charlie, Banerjee Susana, Oza Amit, González-Martín Antonio, Aghajanian Carol, Bradley William, Mathews Cara, Liu Joyce, Lowe Elizabeth S, Bloomfield Ralph, DiSilvestro Pa |
Olaparib maintenance monotherapy in platinum-sensitive, relapsed ovarian cancer without germline BRCA mutations: OPINION Phase IIIb study design. Future oncology (London, England) 2019 9 15 (32): 3651-3663. Poveda Andres M, Davidson Richard, Blakeley Christopher, Milner Alv |
Germline BRCA1 Mutation Detected in a Multiple Endocrine Neoplasia Type 2 Case With RET Codon 634 Mutation. Frontiers in genetics 2019 7 10 544. Sarkadi Balázs, Baghy Kornélia, Sápi Zoltán, Nyir? Gábor, Likó István, Patócs Atti |
Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China. International journal of cancer 2019 Feb . Deng Mei, Chen Hui-Hui, Zhu Xuan, Luo Meng, Zhang Kun, Xu Chun-Jing, Hu Kai-Min, Cheng Pu, Zhou Jiao-Jiao, Zheng Shu, Chen Yi-Di |
A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy. Journal of ovarian research 2020 9 13 (1): 112. Pan Yinglian, Jia Li Ping, Liu Yuzhu, Han Yiyu, Li Qian, Zou Qin, Zhang Zhongpei, Huang Jin, Deng Qingch |
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer. JCO precision oncology 2020 9 4 . Liu Ying L, Selenica Pier, Zhou Qin, Iasonos Alexia, Callahan Margaret, Feit Noah Z, Boland Julia, Vazquez-Garcia Ignacio, Mandelker Diana, Zehir Ahmet, Burger Robert A, Powell Daniel J, Friedman Claire, Cadoo Karen, Grisham Rachel, Konner Jason A, O'Cearbhaill Roisin E, Aghajanian Carol, Reis-Filho Jorge S, Weigelt Britta, Zamarin Dmitr |
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 8 38 (30): 3528-3537. DiSilvestro Paul, Colombo Nicoletta, Scambia Giovanni, Kim Byoung-Gie, Oaknin Ana, Friedlander Michael, Lisyanskaya Alla, Floquet Anne, Leary Alexandra, Sonke Gabe S, Gourley Charlie, Banerjee Susana, Oza Amit, González-Martín Antonio, Aghajanian Carol A, Bradley William H, Mathews Cara A, Liu Joyce, Lowe Elizabeth S, Bloomfield Ralph, Moore Kathleen |
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Oncology 2020 8 21 (10): 1269-1282. Diéras Véronique, Han Hyo S, Kaufman Bella, Wildiers Hans, Friedlander Michael, Ayoub Jean-Pierre, Puhalla Shannon L, Bondarenko Igor, Campone Mario, Jakobsen Erik H, Jalving Mathilde, Oprean Cristina, Palácová Marketa, Park Yeon Hee, Shparyk Yaroslav, Yañez Eduardo, Khandelwal Nikhil, Kundu Madan G, Dudley Matthew, Ratajczak Christine K, Maag David, Arun Banu |
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific reports 2020 6 10 (1): 9688. Liu Jingjing, Prager-van der Smissen Wendy J C, Collée J Margriet, Bolla Manjeet K, Wang Qin, Michailidou Kyriaki, Dennis Joe, Ahearn Thomas U, Aittomäki Kristiina, Ambrosone Christine B, Andrulis Irene L, Anton-Culver Hoda, Antonenkova Natalia N, Arndt Volker, Arnold Norbert, Aronson Kristan J, Augustinsson Annelie, Auvinen Päivi, Becher Heiko, Beckmann Matthias W, Behrens Sabine, Bermisheva Marina, Bernstein Leslie, Bogdanova Natalia V, Bogdanova-Markov Nadja, Bojesen Stig E, Brauch Hiltrud, Brenner Hermann, Briceno Ignacio, Brucker Sara Y, Brüning Thomas, Burwinkel Barbara, Cai Qiuyin, Cai Hui, Campa Daniele, Canzian Federico, Castelao Jose E, Chang-Claude Jenny, Chanock Stephen J, Choi Ji-Yeob, Christiaens Melissa, Clarke Christine L, , Couch Fergus J, Czene Kamila, Daly Mary B, Devilee Peter, Dos-Santos-Silva Isabel, Dwek Miriam, Eccles Diana M, Eliassen A Heather, Fasching Peter A, Figueroa Jonine, Flyger Henrik, Fritschi Lin, Gago-Dominguez Manuela, Gapstur Susan M, García-Closas Montserrat, García-Sáenz José A, Gaudet Mia M, Giles Graham G, Goldberg Mark S, Goldgar David E, Guénel Pascal, Haiman Christopher A, Håkansson Niclas, Hall Per, Harrington Patricia A, Hart Steven N, Hartman Mikael, Hillemanns Peter, Hopper John L, Hou Ming-Feng, Hunter David J, Huo Dezheng, , Ito Hidemi, Iwasaki Motoki, Jakimovska Milena, Jakubowska Anna, John Esther M, Kaaks Rudolf, Kang Daehee, Keeman Renske, Khusnutdinova Elza, Kim Sung-Won, Kraft Peter, Kristensen Vessela N, Kurian Allison W, Le Marchand Loic, Li Jingmei, Lindblom Annika, Lophatananon Artitaya, Luben Robert N, Lubi?ski Jan, Mannermaa Arto, Manoochehri Mehdi, Manoukian Siranoush, Margolin Sara, Mariapun Shivaani, Matsuo Keitaro, Maurer Tabea, Mavroudis Dimitrios, Meindl Alfons, Menon Usha, Milne Roger L, Muir Kenneth, Mulligan Anna Marie, Neuhausen Susan L, Nevanlinna Heli, Offit Kenneth, Olopade Olufunmilayo I, Olson Janet E, Olsson Håkan, Orr Nick, Park Sue K, Peterlongo Paolo, Peto Julian, Plaseska-Karanfilska Dijana, Presneau Nadege, Rack Brigitte, Rau-Murthy Rohini, Rennert Gad, Rennert Hedy S, Rhenius Valerie, Romero Atocha, Ruebner Matthias, Saloustros Emmanouil, Schmutzler Rita K, Schneeweiss Andreas, Scott Christopher, Shah Mitul, Shen Chen-Yang, Shu Xiao-Ou, Simard Jacques, Sohn Christof, Southey Melissa C, Spinelli John J, Tamimi Rulla M, Tapper William J, Teo Soo H, Terry Mary Beth, Torres Diana, Truong Thérèse, Untch Michael, Vachon Celine M, van Asperen Christi J, Wolk Alicja, Yamaji Taiki, Zheng Wei, Ziogas Argyrios, Ziv Elad, Torres-Mejía Gabriela, Dörk Thilo, Swerdlow Anthony J, Hamann Ute, Schmidt Marjanka K, Dunning Alison M, Pharoah Paul D P, Easton Douglas F, Hooning Maartje J, Martens John W M, Hollestelle Antoinet |
Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation. Cancer medicine 2020 Jan . Ye Fugui, Huang Liang, Lang Guantian, Hu Xin, Di Genhong, Shao Zhimin, Cao Ayo |
A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer. Gynecologic oncology 2020 1 156 (3): 535-544. Monk Bradley J, Herzog Thomas J, Wang George, Triantos Spyros, Maul Scott, Knoblauch Roland, McGowan Tracy, Shalaby Waleed S W, Coleman Robert |
Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 9 27 (22): 6106-6114. van der Wijngaart Hanneke, Hoes Louisa R, van Berge Henegouwen J Maxime, van der Velden Daphne L, Zeverijn Laurien J, Roepman Paul, van Werkhoven Erik, de Leng Wendy W J, Jansen Anne M L, Mehra Niven, Robbrecht Debbie G J, Labots Mariette, de Groot Derk Jan A, Hoeben Ann, Hamberg Paul, Gelderblom Hans, Voest Emile E, Verheul Henk M |
Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy. American journal of clinical oncology 2021 8 44 (10): 519-525. Batra Atul, Tang Patricia A, Cheung Winson |
Biomarker Analyses in the Phase 3 ASCENT Study of Sacituzumab Govitecan Versus Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2021 Jun . Bardia A, Tolaney S M, Punie K, Loirat D, Oliveira M, Kalinsky K, Zelnak A, Aftimos P, Dalenc F, Sardesai S, Hamilton E, Sharma P, Recalde S, Gil E C, Traina T, O'Shaughnessy J, Cortes J, Tsai M, Vahdat L, Diéras V, Carey L A, Rugo H S, Goldenberg D M, Hong Q, Olivo M, Itri L M, Hurvitz S |
Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial. Therapeutic advances in medical oncology 2021 12 13 17588359211059601. Ayoub Jean-Pierre, Wildiers Hans, Friedlander Michael, Arun Banu K, Han Hyo S, Puhalla Shannon, Shparyk Yaroslav, Jakobsen Erik H, Wu Meijing, Bach Bruce A, Feng Dai, Ratajczak Christine K, Maag David, Diéras Véroniq |
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial. Annals of oncology : official journal of the European Society for Medical Oncology 2022 6 33 (10): 1021-1028. Frenel J S, Kim J W, Aryal N, Asher R, Berton D, Vidal L, Pautier P, Ledermann J A, Penson R T, Oza A M, Korach J, Huzarski T, Pignata S, Colombo N, Park-Simon T W, Tamura K, Sonke G S, Freimund A E, Lee C K, Pujade-Lauraine |
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations. Current oncology (Toronto, Ont.) 2022 4 29 (4): 2776-2791. Neviere Zoé, Coquan Elodie, Brachet Pierre-Emmanuel, Meriaux Emeline, Bonnet Isabelle, Krieger Sophie, Castéra Laurent, Vaur Dominique, Boulouard Flavie, Leconte Alexandra, Lequesne Justine, Lelaidier Anais, Ricou Agathe, Joly Floren |
Exposure-Response Model With Time-Varying Predictors to Estimate the Effects of Veliparib in Combination With Carboplatin/Paclitaxel and as Monotherapy: Veliparib Phase 3 Study in BRCA-Mutated Advanced Breast Cancer (BROCADE3) Trial. Journal of clinical pharmacology 2022 4 62 (10): 1236-1246. Stodtmann Sven, Eckert Doerthe, Joshi Rujuta, Nuthalapati Silpa, Ratajczak Christine K, Menon Rajeev, Mensing Sven, Xiong H |
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis. Gynecologic oncology 2022 1 164 (3): 498-504. Poveda A, Lheureux S, Colombo N, Cibula D, Lindemann K, Weberpals J, Bjurberg M, Oaknin A, Sikorska M, González-Martín A, Madry R, Pérez M J Rubio, Ledermann J, Davidson R, Blakeley C, Bennett J, Barnicle A, Škof |
Olaparib and celarasertib (AZD6738) in patients with triple negative advanced breast cancer: results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Alistair Ring, Lucy S Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr, Andrew M Wardley, Bora Gurel, Iain R Macpherson, Ruth Riisnaes, Richard D Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C Winter, Kathryn Dunne, Ellen Copson, Tamas Hickish, Russell Burcombe, Kat Randle, Violeta Serra, Alba Llop-Guevara, Judith M Bliss, Nicholas C Turn |
Metastatic lung adenocarcinoma with BRCA2 mutation and longstanding disease control on olaparib, developing triple negative breast adenocarcinoma with additional BRCA2 reversion mutation: a case report. Journal of medical case reports 2023 9 17 (1): 407. Auro Del Giglio, Beatriz da Costa Aguiar Alves, André Márcio Murad, Fernando Luiz Affonso Fonse |
Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression. Cancers 2023 8 15 (15): . Sungun Bang, Dongju Won, Saeam Shin, Kang Su Cho, Jae Won Park, Jongsoo Lee, Young Deuk Choi, Suwan Kang, Seung-Tae Lee, Jong Rak Choi, Hyunho H |
Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer research 2023 6 43 (7): 2941-2949. Christian Rocca, Giulia Rocca, Pietro Zampieri, Lucio Dell'atti, Nicoletta Bianchi, Carmelo Ippolito, Gianluca Aguia |
Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing. Anticancer research 2023 4 43 (5): 1891-1900. Joanna Lopacinska-Joergensen, Douglas V N P Oliveira, Tim Svenstrup Poulsen, Claus K Hoegdall, Estrid V Hoegda |
Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 11 JCO2300339. Joaquin Mateo, Johann S de Bono, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Mustafa Özgüro?lu, Niven Mehra, Nobuaki Matsubara, Jae Young Joung, Charles Padua, Ernesto Korbenfeld, Jinyu Kang, Helen Marshall, Zhongwu Lai, Alan Barnicle, Christian Poehlein, Natalia Lukashchuk, Maha Hussa |
Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 10 . Paul Stockhammer, Michael Grant, Anna Wurtz, Giorgia Foggetti, F Expósito, Jianlei Gu, Hongyu Zhao, Jungmin Choi, Sangyun Chung, Fangyong Li, Zenta Walther, Julia Dietz, Emily Duffield, Scott Gettinger, Katerina Politi, Sarah B Goldbe |
Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse. Journal of ovarian research 2023 10 16 (1): 209. Yana Ma, Jiale Liu, Ning Li, Hualei Bu, Yongwen Huang, Chengjuan Jin, Hao Wen, Shuai Feng, Hui Zhang, Xiaorong Yang, Beihua Kong, Lingying Wu, Kun So |
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO open 2023 10 8 (6): 102041. S Joris, H Denys, J Collignon, M Rasschaert, D T'Kint de Roodenbeke, F P Duhoux, J-L Canon, S Tejpar, J Mebis, L Decoster, P Aftimos, J De Grè |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: